Skip to content
Home
About Us
Longevity Platform
Bio101
BIO101 in Sarcopenia
BIO101 in Obesity
Biophytis Biopharmaceutical
Other Projects
Resources
Posters & Publications
Scientific Press Releases
Recruitment
Investors
Stock Information
Corporate Presentation
Letter to shareholders
Press Releases
General Meetings
AMF Regulated Information
SEC Filings
Convertible bonds
Pre-financed vouchers (PFW)
Obligations Hexagon
Obligations Hexagon
Contact for Investors
Contact
TNC FlipBook Classic items
PR_JV_Biophytis_x_Consortium 13102025_EN
By
admin
October 12, 2025
PR_Events_Biophytis_Q4_30092025_EN
By
admin
September 29, 2025
CP_Conferences_Biophytis_T4_30092025_FR
By
admin
September 29, 2025
Biophytis-EMBRAPII-OBA_EN
By
admin
September 14, 2025
Biophytis-EMBRAPII-OBA_FR
By
admin
September 14, 2025
PR_Detailed_Plan_SARA_EN
By
admin
September 10, 2025
CP_Plan_détaillé_SARA_FR
By
admin
September 10, 2025
Approval_EMA_Biophytis_Phase_2_OBA_Sept_2025_EN
By
admin
September 2, 2025
Approval_EMA_Biophytis_Phase_2_OBA_Sept_2025_FR
By
admin
September 2, 2025
01092025_PR_OBA_Study_Strategy
By
admin
August 31, 2025
←
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
…
18
19
20
21
22
…
23
24
25
26
27
28
29
30
31
32
33
34
→
Go to Top
Home
About Us
Longevity Platform
Bio101
BIO101 in Sarcopenia
BIO101 in Obesity
Biophytis Biopharmaceutical
Other Projects
Resources
Posters & Publications
Scientific Press Releases
Recruitment
Investors
Stock Information
Corporate Presentation
Letter to shareholders
Press Releases
General Meetings
AMF Regulated Information
SEC Filings
Convertible bonds
Pre-financed vouchers (PFW)
Obligations Hexagon
Obligations Hexagon
Contact for Investors
Contact
